PremiumCompany AnnouncementsAlloVir Appoints Vikas Sinha as New CEO AlloVir and Kalaris Merge to Advance Retinal Therapies AlloVir to combine with Kalaris Therapeutics in all-stock transaction PremiumCompany AnnouncementsAlloVir Faces Delisting Risk, Considers Reverse Split to Comply Allovir Inc (ALVR) Q4 Earnings Cheat Sheet SHAREHOLDER ALERT: Potential Recovery for AlloVir, Inc. (ALVR) Investors PremiumThe FlyAlloVir downgraded to Equal Weight from Overweight at Morgan Stanley AlloVir downgraded to Market Perform from Outperform at Leerink Nike downgraded, Waste Management upgraded: Wall Street’s top analyst calls